Commentary by Daniel Fine MD
Faculty Peer Reviewed
Diabetic nephropathy is the most frequent cause of end-stage kidney disease in the United States, Europe and Japan. Large scale randomized controlled trials have shown that …
Category: Renal
Clinical Correlations
Diseases 2.0: Uric acid stones linked to diabetes
July 3, 2008
Diseases 2.0 – Bringing you the latest updates on disease pathophysiology and treatment
Commentary By David Goldfarb, M.D. Professor of Medicine, NYU Medical Center, Chief Nephrology Section VA New York Harbor
At the recent meeting of …
Grand Rounds: “Nephrogenic systemic fibrosis”
June 5, 2008
Commentary by Jatin Roper MD, PGY-3
Medical Grand Rounds today was presented last week by Dr. Shawn Cowper, Assistant Professor of Dermatology and Pathology at Yale University School of Medicine. …
Grand Rounds: “Hyponatremia: Something Old, Something New”
January 30, 2008
Commentary by Elizabeth Haskins MD, PGY-3
This week’s Grand Rounds was delivered by Dr. Tomas Berl, Chief of the Nephrology Division at the University of Colorado Health Sciences Center in Denver. Dr. Berl’s current …
Tumor Lysis Syndrome and the Role of Urinary Alkalinization
September 13, 2007
Commentary by Bani Chander MD, PGY-2, and Sergio Obligado MD, Attending Physician, Nephrology
Tumor lysis syndrome (TLS) is characterized by a group of metabolic abnormalities including hyperkalemia, hyperuricemia, and hyperphosphatemia with secondary hypocalcemia, …
X-Ray Visions: Update on Nephrogenic Systemic Fibrosis and Gadolinium Contrast MRI
July 24, 2007
Commentary by Andrew Hardie MD, Body MRI Fellow, NYU Dept of Radiology
The recent discovery of a link between Nephrogenic Systemic Fibrosis (NSF) and the administration of gadolinium contrast for MRI examinations has sent the imaging world scrambling. …
Hyperparathyroidism in Chronic Kidney Disease
June 13, 2007
Commentary by Sarah Berry MD, PGY-3 and Joseph Weisstuch, MD Clinical Assistant Professor of Medicine, Divsion of Nephrology
Case: Mr. K is a 59 year old gentleman with a past medical history of hypertension, non-insulin dependent diabetes mellitus, dyslipidemia …
Recent Developments in the Treatment of Renal Cell Carcinoma
May 31, 2007
Commentary by Michael Seidman MD, Chief Oncology Fellow
New treatment options for both early and advanced Renal Cell Cancer have recently been published. Traditionally, treatment for early stage disease was partial or radical nephrectomy. In the metastatic …